Ottobock SE & Co. KGaA (ETR:OBCK)

Market Cap	3.73B
Revenue (ttm)	1.68B +4.7%
Net Income	90.20M +198.7%
EPS	1.44 +197.2%
Shares Out	63.99M
PE Ratio	40.59
Forward PE	19.63
Dividend	0.97 (1.66%)
Ex-Dividend Date	n/a

Volume	8,817
Average Volume	18,808
Open	57.30
Previous Close	57.60
Day's Range	56.50 - 58.30
52-Week Range	45.56 - 76.35
Beta	n/a
RSI	56.48
Earnings Date	May 6, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 10,365
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: OBCK

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.